Takeda Pharmaceutical Company (TAK)
NYSE:TAK
Holding TAK?
Track your performance easily

Takeda Pharmaceutical Company (TAK) Cash flow

1,217 Followers

Takeda Pharmaceutical Company Cash Flow

TAK's free cash flow for Q4 2023 was ¥―. For the 2023 fiscal year, TAK's free cash flow was decreased by ¥71.24B and operating cash flow was ¥―. See a summary of the company’s cash flow.
Cash Flow
TTM
Mar 24Mar 23Mar 22Mar 21Mar 20
Operating Cash Flow
¥ 599.22B¥ 716.34B¥ 805.71B¥ 948.02B¥ 1.01T¥ 669.75B
Investing Cash Flow
¥ -73.90B¥ -463.86B¥ -607.10B¥ -198.13B¥ 393.53B¥ 292.12B
Financing Cash Flow
¥ -486.83B¥ -354.42B¥ -602.36B¥ -927.36B¥ -1.09T¥ -1.01T
Cash Flow From Discontinued Operation
-----¥ 0.00
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
¥ 1.48T¥ 457.80B¥ 445.94B¥ 788.76B¥ 966.22B¥ 637.61B
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
------
Issuance Of Debt
-¥ 1.51B¥ -325.07B¥ -600.48B¥ 1.18T¥ 496.19B
Repayment Of Debt
¥ -276.97B¥ -375.49B¥ -400.07B¥ -849.81B¥ -1.69T¥ -731.06B
Free Cash Flow
¥ 507.99B¥ 244.22B¥ 172.98B¥ 763.80B¥ 774.46B¥ 452.04B
Domestic Sales
------
Foreign Sales
------
Currency in JPY

Takeda Pharmaceutical Company Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis